The states with the highest rates of HIV diagnoses in 2022 included Georgia, Louisiana, and Florida. However, the states with the highest number of people with HIV were Texas, California, and Florida. In Texas, there were around 4,896 people diagnosed with HIV. HIV/AIDS diagnoses In 2022, there were an estimated 38,043 new HIV diagnoses in the United States, a slight increase compared to the year before. Men account for the majority of these new diagnoses. There are currently around 1.2 million people living with HIV in the United States. Deaths from HIV The death rate from HIV has decreased significantly over the past few decades. In 2023, there were only 1.3 deaths from HIV per 100,000 population, the lowest rate since the epidemic began. However, the death rate varies greatly depending on race or ethnicity, with the death rate from HIV for African Americans reaching 19.2 per 100,000 population in 2022, compared to just three deaths per 100,000 among the white population.

These data were reported to the NYC DOHMH by March 31, 2021 This dataset includes data on new diagnoses of HIV and AIDS in NYC for the calendar years 2016 through 2020. Reported cases and case rates (per 100,000 population) are stratified by United Hospital Fund (UHF) neighborhood, sex, and race/ethnicity. Note: - Cells marked "NA" cannot be calculated because of cell suppression or 0 denominator.

The AIDS Public Information Data Set (APIDS) for years 1981-2002 on CDC WONDER online database contains counts of AIDS (Acquired Immune Deficiency Syndrome) cases reported by state and local health departments, by demographics; location (region and selected metropolitan areas); case-definition; month/year and quarter-year of diagnosis, report, and death (if applicable); and HIV exposure group (risk factors for AIDS). Data are produced by the US Department of Health and Human Services (US DHHS), Public Health Service (PHS), Centers for Disease Control and Prevention (CDC), National Center for HIV, STD and TB Prevention (NCHSTP), Division of HIV/AIDS Prevention (DHP).

United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.500 % in 2014. This stayed constant from the previous number of 0.500 % for 2013. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.500 % from Dec 2008 (Median) to 2014, with 7 observations. The data reached an all-time high of 0.500 % in 2014 and a record low of 0.500 % in 2014. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.; ; UNAIDS estimates.; Weighted Average;

HIV/AIDS data from the HIV Surveillance Annual Report Data reported to the HIV Epidemiology Program by March 31, 2022. All data shown are for people ages 18 and older. Borough-wide and citywide totals may include cases assigned to a borough with an unknown UHF or assigned to NYC with an unknown borough, respectively. Therefore, UHF totals may not sum to borough totals and borough totals may not sum to citywide totals.""

HIV/AIDS deaths in the U.S. have dropped significantly in recent years. In 1995, the death rate from HIV per 100,000 people was ****. That number has since decreased to *** per 100,000 as of 2023. The reduction in the HIV death rate in the U.S. can be attributed to an increase in access to HIV medications. HIV/AIDS in the U.S. Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) cause a systemic viral infection that damages the immune system. AIDS is a syndrome that is caused by HIV. AIDS is when the immune system is severely weakened by HIV and the body can no longer fight off infections. Among all U.S. states, Georgia, followed by Florida and Louisiana, had the highest rates of new HIV diagnoses in 2022. HIV/AIDS treatments in the U.S. HIV/AIDS treatments include antiretroviral medications to reduce the levels of HIV within the body. The largest funders for HIV/AIDS medications and research are the National Institutes of Health (NIH) and the Ryan White Program. The top HIV drug worldwide, based on revenue generated in 2023 was Biktarvy. Around the world, access to antiretroviral treatment has increased dramatically in recent years, a huge step in reducing the number of HIV-related deaths. There is currently no cure for HIV.

This directory is for at-risk for HIV and eligible persons living with HIV in New York City seeking HIV medical and supportive services. The agencies and their listed programs receive CDC and Ryan White Part-A funding to provide: Targeted-Testing among Priority Populations, Food and Nutrition Services, Health Education and Risk Reduction Services, Harm Reduction Services, Legal Services, Mental Health Services, Case Management and Care Coordination Services, and Supportive Counseling Services. To be eligible to recieve these services, prospective clients must: 1)be HIV-positive; 2) have a total household income below 435% of the Federal Poverty Level (FPL) (this is the same as the income eligible guidelines for the New York State AIDS Drug Assistance Program (ADAP) and higher than the income eligiblity guidelines for Medicaid in New York State); and 3) reside in New York City or the counties of Westchester, Rockland, and Putnam. For providers, to make a referral, please contact the program directly using the information provided in the diretory (please be sure to call before directing clients to the program). When making a referral, you may also find it useful to talk to your client about executing a release of information form authorizing you to share confidential health and HIV-related information with another service provider in order to coordinate care (for more information, go to https://www.health.ny.gov/diseases/aids/providers/forms/informedconsent.htm).

In 2024, the number of diagnosed HIV cases in Mexico amounted to approximately 19,000. That year, the State of Mexico, Veracruz, and Mexico City were the federative entities with the highest number of people diagnosed with the human immunodeficiency virus (HIV), with more than 1,000 patients each. Moreover, most registered HIV cases in the Latin American country between 1984 and 2023 corresponded to men. People living with HIV in Latin America In the last few years, the number of people living with HIV in Latin America has been increasing. According to recent estimates, the number of individuals living with this condition rose from around 1.6 million in 2013 to almost 2.2 million by 2022. From a country perspective, Brazil and Mexico were the Latin American nations where most people were living with the disease, reaching approximately 990,000 and 370,000 patients, respectively. ART is more costly in Latin America HIV is commonly treated through antiretroviral therapy (ART), a drug-based treatment aimed at reducing the viral load in the blood to help control the development of the disease while improving the health of those infected. Although the share of deaths among people living with HIV due to causes unrelated to AIDS increased globally since 2010, there are still inequalities in the access to ART therapy. As of 2022, Latin America and the Caribbean recorded the highest average price per person for HIV antiretroviral therapy compared to other regions worldwide.

This dataset contains surveillance data on diagnoses of HIV for the United States in estimates rates and numbers for Human Immunodeficiency Virus (HIV) infection diagnosis and stage 3 infection Acquired Immunodeficiency Syndrome (AIDS) as collected by the Centers for Disease Control and Prevention (CDC).

Prevalence of HIV, total (% of population ages 15-49) in United States was reported at 0.4 % in 2021, according to the World Bank collection of development indicators, compiled from officially recognized sources. United States - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

United States US: Incidence of HIV: per 1,000 Uninfected Population data was reported at 0.110 Ratio in 2019. This stayed constant from the previous number of 0.110 Ratio for 2018. United States US: Incidence of HIV: per 1,000 Uninfected Population data is updated yearly, averaging 0.120 Ratio from Dec 2010 (Median) to 2019, with 10 observations. The data reached an all-time high of 0.130 Ratio in 2012 and a record low of 0.110 Ratio in 2019. United States US: Incidence of HIV: per 1,000 Uninfected Population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates.;Weighted average;This is the Sustainable Development Goal indicator 3.3.1 [https://unstats.un.org/sdgs/metadata/].

United States US: Incidence of HIV: % of Uninfected Population Aged 15-49 data was reported at 0.020 % in 2014. This stayed constant from the previous number of 0.020 % for 2013. United States US: Incidence of HIV: % of Uninfected Population Aged 15-49 data is updated yearly, averaging 0.030 % from Dec 2008 (Median) to 2014, with 7 observations. The data reached an all-time high of 0.030 % in 2012 and a record low of 0.020 % in 2014. United States US: Incidence of HIV: % of Uninfected Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Number of new HIV infections among uninfected populations ages 15-49 expressed per 100 uninfected population in the year before the period.; ; UNAIDS estimates.; Weighted Average;

Location and facility information for places in New York City that provide HIV testing.

Local Law 14 (2016) requires that NYCDOE provide citywide Health Education data, disaggregated by community school district, city council district and each individual school. This provides information about the number and percent of students scheduled for at least one semester of health education as reported through the STARS database. NYSED mandates HIV/AIDS instruction with a set number of lessons for every student, every year. There are five required lessons per year for grade levels of K-6 and six required lessons for grade level 7-8; teachers must use the NYCDOE HIV\AIDS curriculum.

Count and rates were provided by MDHHS Epidemiologists. Rates were calculated using population data from the 5-Year American Community Survey.

BackgroundIn the generalised epidemics of sub-Saharan Africa (SSA), human immunodeficiency virus (HIV) prevalence shows patterns of clustered micro-epidemics. We mapped and characterised these high-prevalence areas for young adults (15–29 years of age), as a proxy for areas with high levels of transmission, for 7 countries in Eastern and Southern Africa: Kenya, Malawi, Mozambique, Tanzania, Uganda, Zambia, and Zimbabwe.Methods and findingsWe used geolocated survey data from the most recent United States Agency for International Development (USAID) demographic and health surveys (DHSs) and AIDS indicator surveys (AISs) (collected between 2008–2009 and 2015–2016), which included about 113,000 adults—of which there were about 53,000 young adults (27,000 women, 28,000 men)—from over 3,500 sample locations. First, ordinary kriging was applied to predict HIV prevalence at unmeasured locations. Second, we explored to what extent behavioural, socioeconomic, and environmental factors explain HIV prevalence at the individual- and sample-location level, by developing a series of multilevel multivariable logistic regression models and geospatially visualising unexplained model heterogeneity. National-level HIV prevalence for young adults ranged from 2.2% in Tanzania to 7.7% in Mozambique. However, at the subnational level, we found areas with prevalence among young adults as high as 11% or 15% alternating with areas with prevalence between 0% and 2%, suggesting the existence of areas with high levels of transmission Overall, 15.6% of heterogeneity could be explained by an interplay of known behavioural, socioeconomic, and environmental factors. Maps of the interpolated random effect estimates show that environmental variables, representing indicators of economic activity, were most powerful in explaining high-prevalence areas. Main study limitations were the inability to infer causality due to the cross-sectional nature of the surveys and the likely under-sampling of key populations in the surveys.ConclusionsWe found that, among young adults, micro-epidemics of relatively high HIV prevalence alternate with areas of very low prevalence, clearly illustrating the existence of areas with high levels of transmission. These areas are partially characterised by high economic activity, relatively high socioeconomic status, and risky sexual behaviour. Localised HIV prevention interventions specifically tailored to the populations at risk will be essential to curb transmission. More fine-scale geospatial mapping of key populations,—such as sex workers and migrant populations—could help us further understand the drivers of these areas with high levels of transmission and help us determine how they fuel the generalised epidemics in SSA.

Abstract

The 2005 Vietnam Population and AIDS Indicator Survey (VPAIS) was designed with the objective of obtaining national and sub-national information about program indicators of knowledge, attitudes and sexual behavior related to HIV/AIDS. Data collection took place from 17 September 2005 until mid-December 2005.

The VPAIS was implemented by the General Statistical Office (GSO) in collaboration with the National Institute of Hygiene and Epidemiology (NIHE). ORC Macro provided financial and technical assistance for the survey through the USAID-funded MEASURE DHS program. Financial support was provided by the Government of Vietnam, the United States President’s Emergency Plan for AIDS Relief, the United States Agency for International Development (USAID), and the United States Centers for Disease Control and Prevention/Global AIDS Program (CDC/GAP).

The survey obtained information on sexual behavior, and knowledge, attitudes, and behavior regarding HIV/AIDS. In addition, in Hai Phong province, the survey also collected blood samples from survey respondents in order to estimate the prevalence of HIV. The overall goal of the survey was to provide program managers and policymakers involved in HIV/AIDS programs with strategic information needed to effectively plan, implement and evaluate future interventions.

The information is also intended to assist policymakers and program implementers to monitor and evaluate existing programs and to design new strategies for combating the HIV/AIDS epidemic in Vietnam. The survey data will also be used to calculate indicators developed by the United Nations General Assembly Special Session on HIV/AIDS (UNGASS), UNAIDS, WHO, USAID, the United States President’s Emergency Plan for AIDS Relief, and the HIV/AIDS National Response.

The specific objectives of the 2005 VPAIS were: • to obtain information on sexual behavior. • to obtain accurate information on behavioral indicators related to HIV/AIDS and other sexually transmitted infections. • to obtain accurate information on HIV/AIDS program indicators. • to obtain accurate estimates of the magnitude and variation in HIV prevalence in Hai Phong Province.

Geographic coverage

National coverage

Analysis unit

• Household
• Women age 15-49
• Men age 15-49

Kind of data

Sample survey data [ssd]

Sampling procedure

The sampling frame for the 2005 Vietnam Population and AIDS Indicator Survey (VPAIS) was the master sample used by the General Statistical Office (GSO) for its annual Population Change Survey (PCS 2005). The master sample itself was constructed in 2004 from the 1999 Population and Housing Census. As was true for the VNDHS 1997 and the VNDHS 2002 the VPAIS 2005 is a nationally representative sample of the entire population of Vietnam.

The survey utilized a two-stage sample design. In the first stage, 251 clusters were selected from the master sample. In the second stage, a fixed number of households were systematically selected within each cluster, 22 households in urban areas and 28 in rural areas.

The total sample of 251 clusters is comprised of 97 urban and 154 rural clusters. HIV/AIDS programs have focused efforts in the four provinces of Hai Phong, Ha Noi, Quang Ninh and Ho Chi Minh City; therefore, it was determined that the sample should be selected to allow for representative estimates of these four provinces in addition to the national estimates. The selected clusters were allocated as follows: 35 clusters in Hai Phong province where blood samples were collected to estimate HIV prevalence; 22 clusters in each of the other three targeted provinces of Ha Noi, Quang Ninh and Ho Chi Minh City; and the remaining 150 clusters from the other 60 provinces throughout the country.

Prior to the VPAIS fieldwork, GSO conducted a listing operation in each of the selected clusters. All households residing in the sample points were systematically listed by teams of enumerators, using listing forms specially designed for this activity, and also drew sketch maps of each cluster. A total of 6,446 households were selected. The VPAIS collected data representative of: • the entire country, at the national level • for urban and rural areas • for three regions (North, Central and South), see Appendix for classification of regions. • for four target provinces: Ha Noi, Hai Phong, Quang Ninh and Ho Chi Minh City.

All women and men aged 15-49 years who were either permanent residents of the sampled households or visitors present in the household during the night before the survey were eligible to be interviewed in the survey. All women and men in the sample points of Hai Phong who were interviewed were asked to voluntarily give a blood sample for HIV testing. For youths aged 15-17, blood samples were drawn only after first obtaining consent from their parents or guardians.

(Refer Appendix A of the final survey report for details of sample implementation)

Mode of data collection

Face-to-face [f2f]

Research instrument

Two questionnaires were used in the survey, the Household Questionnaire and the Individual Questionnaire for women and men aged 15-49. The content of these questionnaires was based on the model AIDS Indicator Survey (AIS) questionnaires developed by the MEASURE DHS program implemented by ORC Macro.

In consultation with government agencies and local and international organizations, the GSO and NIHE modified the model questionnaires to reflect issues in HIV/AIDS relevant to Vietnam. These questionnaires were then translated from English into Vietnamese. The questionnaires were further refined after the pretest.

The Household Questionnaire was used to list all the usual members and visitors in the selected households. Some basic information was collected on the characteristics of each person listed, including age, sex, relationship to the head of the household, education, basic material needs, survivorship and residence of biological parents of children under the age of 18 years and birth registration of children under the age of 5 years. The main purpose of the Household Questionnaire was to identify women and men who were eligible for the individual interview. The Household Questionnaire also collected information on characteristics of the household’s dwelling unit, such as the source of drinking water, type of toilet facilities, type of material used in the flooring of the house, and ownership of various durable goods, in order to allow for the calculation of a wealth index. The Household Questionnaire also collected information regarding ownership and use of mosquito nets.

The Individual Questionnaire was used to collect information from all women and men aged 15-49 years.

All questionnaires were administered in a face-to-face interview. Because cultural norms in Vietnam restrict open discussion of sexual behavior, there is concern that this technique may contribute to potential under-reporting of sexual activity, especially outside of marriage.

All aspects of VPAIS data collection were pre-tested in July 2005. In total, 24 interviewers (12 men and 12 women) were involved in this task. They were trained for thirteen days (including three days of fieldwork practice) and then proceeded to conduct the survey in the various urban and rural districts of Ha Noi. In total, 240 individual interviews were completed during the pretest. The lessons learnt from the pretest were used to finalize the survey instruments and logistical arrangements for the survey and blood collection.

Cleaning operations

The data processing of the VPAIS questionnaire began shortly after the fieldwork commenced. The first stage of data editing was done by the field editors, who checked the questionnaires for completeness and consistency. Supervisors also reviewed the questionnaires in the field. The completed questionnaires were then sent periodically to the GSO in Ha Noi by mail for data processing.

The office editing staff first checked that questionnaires of all households and eligible respondents had been received from the field. The data were then entered and edited using CSPro, a software package developed collaboratively between the U.S. Census Bureau, ORC Macro, and SerPRO to process complex surveys. All data were entered twice (100 percent verification). The concurrent processing of the data was a distinct advantage for data quality, as VPAIS staff was able to advise field teams of errors detected during data entry. The data entry and editing phases of the survey were completed by the end of December 2005.

Response rate

A total of 6,446 households were selected in the sample, of which 6,346 (98 percent) were found to be occupied at the time of the fieldwork. Occupied households include dwellings in which the household was present but no competent respondent was home, the household was present but refused the interview, and dwellings that were not found. Of occupied households, 6,337 were interviewed, yielding a household response rate close to 100 percent.

All women and men aged 15-49 years who were either permanent residents of the sampled households or visitors present in the household during the night before the survey were eligible to be interviewed in the survey. Within interviewed households, a total of 7,369 women aged 15-49 were identified as eligible for interview, of whom 7,289 were interviewed, yielding a response rate to the Individual interview of 99 percent among women. The high response rate was also achieved in male interviews. Among the 6,788 men aged 15-49 identified as eligible for interview, 6,707 were successfully interviewed, yielding a response rate of 99 percent.

Sampling error

This is a list of over 325 venues, across the five boroughs that actively distribute free safer sex products. Product availability varies by venue.

The NYC Condom Availability Program maintains a robust list of active venues where New York City (NYC) residents may access free safer sex products across all 5 boroughs of NYC. This list is updated through a variety of mechanisms supported by the NYC Department of Health and Mental Hygiene (NYC DOHMH). At minimum, different sub-sets of this dataset are updated monthly by several vetted DOHMH contracted agencies. Other subsets of this dataset are updated in real-time by NYC Safer Sex Portal users. This entire dataset is refreshed in OpenData on a daily basis. This dataset shows where New York City residents can access NYC free safer sex products throughout the five boroughs. Each row represents pertinent information related to a single venue which distributes NYC safer sex products. This data is collected and maintained to populate the NYC HealthMap (https://a816-healthpsi.nyc.gov/NYCHealthMap/home/) and may be used by other safer sex product [condom/lubricant] locators or map publically available locations. This dataset does not represent all locations which received orders of free safer sex products from NYC DOHMH nor have the listed venues [locations] been endorsed by NYC DOHMH. Furthermore, while the data is sourced from the NYC HealthMap there could be a lag between what is visible inside the HealthMap’s user interface and what is seen on OpenData. The NYC HealthMap is updated ~hourly while OpenData is updated daily. If there are data discrepancies between your export and what is seen inside OpenData’s “View Data” please clear your browsing history/cache and restart your browser.

This dataset provides information on different indicators like age group, location, race/ethnicity, transmission category for the people diagnosed with HIV.

NAHDAP acquires, preserves and disseminates data relevant to drug addiction and HIV research. By preserving and making available an easily accessible library of electronic data on drug addiction and HIV infection in the United States, NAHDAP offers scholars the opportunity to conduct secondary analysis on major issues of social and behavioral sciences and public policy.